I am an Assistant Attending Physicist in the Radiation Dosimetry Core of the Division of Radiotherapy Physics within the Department of Medical Physics. My clinical service focuses on the commissioning of new treatment machines and treatment planning systems, and on the quality assurance of equipment and patient-specific treatment plans. The objective is to ensure that patients have access to the most advanced and effective radiotherapy technologies and that treatments are delivered safely and accurately. My research interests center on radiation dosimetry, particularly the development and translation of novel technologies into clinical practice. I am also passionate about training and mentoring the next generation of clinicians and scientists.
I received my BS in Physics from the University of Michigan and my PhD in Experimental Particle Physics from the Massachusetts Institute of Technology. Following a postdoctoral research fellowship with the New York Proton Center, I completed the 0+2 clinical residency program at MSK before assuming my current role.
Disclosures
Members of the MSK Community often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community. These activities outside of MSK further our mission, provide productive collaborations, and promote the practical application of scientific discoveries.
MSK requires doctors, faculty members, and leaders to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public. Not all disclosed interests and relationships present conflicts of interest. MSK reviews all disclosed interests and relationships to assess whether a conflict of interest exists and whether formal COI management is needed.
Yunjie Yang discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2024 through disclosure submission in spring 2025). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].
View all disclosures